Effectiveness of telplizumab in teenagers with recently discovered type 1 diabetes.

Published Date: 22 Oct 2023

When teplizumab was administered instead of a placebo, there was a notable improvement in stimulated C-peptide levels at week 78 for patients who had recently been diagnosed with type 1 diabetes (T1D). The percentage of time spent in the target glucose range, the amount of insulin administered, and the change in glycated hemoglobin did not show any significant differences between the groups.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Charles III, King of Kings, is Cancerous.

2.

Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.

3.

Perioperative Anti-PD-1 in Soft-Tissue Sarcoma Boosts Disease-Free Survival

4.

Merck enhances its oncology pipeline by means of a strategic alliance with Hengrui.

5.

WHO releases new R&D landscape analyses highlighting gaps and inequities in cancer research


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot